NVTA

The New York Stock Exchange Will Start Delisting Invitae (NVTA) Stock

The New York Stock Exchange has announced that it will begin the process of delisting NVTA stock based on its "abnormally low" price.

NVTA Stock: Invitae Plunges 78% on the Brink of Bankruptcy

NVTA stock tumbled yesterday amid a report that the firm could declare bankruptcy soon. The shares were halted for news pending. 

Why Is Invitae (NVTA) Stock Down 75% Today?

Although genetic testing specialist Invitae forwarded a compelling idea, the lack of business substance ultimately cratered NVTA stock.

Invitae Layoffs 2023: What to Know About the Latest NVTA Job Cuts

Invitae layoffs are a hot topic on Friday after the genetics company announced a 15% reduction of its workforce to reduce costs.

3 Cathie Wood Stocks to Sell Before It’s Too Late

Not all Cathie Wood Stocks are created equally. Therefore, investors should carefully consider dropping these Cathie Wood Stocks to sell.

3 Penny Stocks That Look Like Intriguing Bets for the Long-Term

Set aside opinions on penny stocks because these three represent companies worth considering as long-term bets.

Why Is Invitae (NVTA) Stock Up 28% Today?

Invitae stock is on the rise Monday with heavy trading of NVTA despite a lack of news from the medical genetics company this morning.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Pre-market stock movers are worth checking out on Monday as we start off the week with all the latest news this morning!

Why Are Gene Editing Stocks EDIT, NVTA, CRSP Up Today?

Gene editing stocks are up today on news that Editas Medicine will present clinical data on June 12. Here's what this means for the sector.

The 7 Best Stocks to Short This Week

For those that want to live extremely dangerously, these questionable companies may represent stocks to short this week.

NVTA Stock Alert: Invitae Announces Data-Sharing Partnership With Simons Searchlight

Shares of NVTA stock are in focus after the company announced a data-sharing collaboration with Simons Searchlight.

Invitae Stock Won’t Be Tripling Again Any Time Soon

Given its poor fundamentals, NVTA stock could continue to give back its recent gains, making it best to avoid it.

The 5 Top Stocks Cathie Wood Is Buying Now

Cathie Wood's ETFs have performed well following the release of July's CPI report. Recent Cathie Wood stocks include NVTA, TDOC and RBLX.

Cathie Wood Is Buying Up Red-Hot Invitae (NVTA) Stock

Shares of NVTA stock closed higher by about 240% yesterday. Cathie Wood's Ark Invest reported purchasing shares prior to earnings.

What Is Going on With 23andMe (ME) Stock Today?

23andMe, Invitae and others are seeing an explosive rally, but investors want to know if ME stock and others can continue to climb.

Why Is Pacific Biosciences (PACB) Stock Up 5% Today?

Shareholders in Pacific Biosciences and PACB stock certainly have a lot to cheer today, as investors go wild for biotech companies.

Cathie Wood Is Doubling Down on Biotech Stocks DNA, NVTA, TDOC

Cathie Wood is at it again. The high-growth fund manager bought a number of biotech stocks this week, adding to her sizable holdings.

What Is Going on With Invitae (NVTA) Stock Today?

After soaring nearly 280% yesterday, Invitae (NVTA) stock is slumping today. The company reported stronger-than-expected Q2 results.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Good morning! We're starting off Thursday with an overview of the biggest pre-market stock movers that traders need to watch!